Invesco Ltd.

NYSE:IVZ Stock Report

Market Cap: US$7.8b

Invesco Valuation

Is IVZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IVZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IVZ ($17.48) is trading below our estimate of fair value ($26.25)

Significantly Below Fair Value: IVZ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IVZ?

Key metric: As IVZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for IVZ. This is calculated by dividing IVZ's market cap by their current revenue.
What is IVZ's PS Ratio?
PS Ratio1.3x
SalesUS$5.89b
Market CapUS$7.79b

Price to Sales Ratio vs Peers

How does IVZ's PS Ratio compare to its peers?

The above table shows the PS ratio for IVZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3x
JHG Janus Henderson Group
2.9x3.9%US$6.7b
AMG Affiliated Managers Group
2.8x2.2%US$5.5b
BEN Franklin Resources
1.3x-1.7%US$10.7b
SEIC SEI Investments
5.2x5.3%US$10.7b
IVZ Invesco
1.3x-3.5%US$7.8b

Price-To-Sales vs Peers: IVZ is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (3x).

Price to Sales Ratio vs Industry

How does IVZ's PS Ratio compare vs other companies in the US Capital Markets Industry?

25 CompaniesPrice / SalesEstimated GrowthMarket Cap
SNEX StoneX Group
0.03xn/aUS$3.04b
CNCK Coincheck Group
0.5xn/aUS$893.65m
OPY Oppenheimer Holdings
0.5xn/aUS$645.20m
BKKT Bakkt Holdings
0.09x-151.2%US$376.78m
IVZ 1.3xIndustry Avg. 3.3xNo. of Companies25PS03.26.49.612.816+
25 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: IVZ is good value based on its Price-To-Sales Ratio (1.3x) compared to the US Capital Markets industry average (3.3x).

Price to Sales Ratio vs Fair Ratio

What is IVZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IVZ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.3x
Fair PS Ratio2x

Price-To-Sales vs Fair Ratio: IVZ is good value based on its Price-To-Sales Ratio (1.3x) compared to the estimated Fair Price-To-Sales Ratio (2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IVZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$17.48
US$18.98
+8.6%
4.5%US$20.00US$17.50n/a16
Dec ’25US$18.09
US$19.14
+5.8%
5.9%US$22.00US$17.50n/a16
Nov ’25US$17.78
US$18.97
+6.7%
6.2%US$22.00US$17.50n/a16
Oct ’25US$17.25
US$17.52
+1.5%
6.1%US$20.00US$16.00n/a16
Sep ’25US$17.09
US$17.53
+2.6%
5.7%US$20.00US$16.00n/a15
Aug ’25US$16.82
US$17.29
+2.8%
6.3%US$20.00US$16.00n/a14
Jul ’25US$14.85
US$16.71
+12.6%
7.0%US$19.50US$15.00n/a14
Jun ’25US$15.71
US$16.70
+6.3%
7.0%US$19.50US$15.00n/a14
May ’25US$14.34
US$16.70
+16.4%
7.0%US$19.50US$15.00n/a14
Apr ’25US$16.49
US$17.80
+7.9%
7.8%US$21.00US$16.00n/a15
Mar ’25US$15.53
US$17.82
+14.7%
7.7%US$21.00US$16.00n/a15
Feb ’25US$16.08
US$17.68
+10.0%
8.7%US$21.00US$15.00n/a15
Jan ’25US$17.84
US$15.64
-12.3%
12.2%US$20.00US$13.00n/a14
Dec ’24US$14.86
US$14.75
-0.7%
7.0%US$17.00US$13.00US$18.0914
Nov ’24US$13.07
US$14.71
+12.6%
7.3%US$17.00US$13.00US$17.7814
Oct ’24US$14.52
US$17.52
+20.6%
7.6%US$21.00US$15.75US$17.2514
Sep ’24US$16.03
US$17.82
+11.2%
6.8%US$21.00US$16.00US$17.0914
Aug ’24US$16.83
US$17.82
+5.9%
6.8%US$21.00US$16.00US$16.8214
Jul ’24US$16.81
US$17.71
+5.4%
9.0%US$21.00US$15.00US$14.8514
Jun ’24US$14.74
US$17.80
+20.8%
8.9%US$21.00US$15.00US$15.7114
May ’24US$16.78
US$17.96
+7.1%
8.4%US$21.00US$15.00US$14.3414
Apr ’24US$16.40
US$18.07
+10.2%
8.2%US$21.00US$15.00US$16.4914
Mar ’24US$17.53
US$18.25
+4.1%
8.8%US$21.00US$14.50US$15.5314
Feb ’24US$18.92
US$18.04
-4.7%
8.4%US$21.00US$14.50US$16.0814
Jan ’24US$17.99
US$17.21
-4.3%
16.4%US$22.00US$11.50US$17.8414
Dec ’23US$19.43
US$15.69
-19.2%
17.5%US$22.00US$11.50US$14.8613

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:13
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Invesco Ltd. is covered by 33 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephen BiggarArgus Research Company
Benjamin BudishBarclays
Roger FreemanBarclays